Emerging role of natriuretic peptides in diabetes mellitus: New approaches for risk stratification

Emerging role of natriuretic peptides in diabetes mellitus: New approaches for risk stratification

Bibliographic Details
Main Authors:	Alexander E Berezin, Alexander A Berezin
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2020-01-01
Series:	Heart and Mind
Subjects:	biomarkers cardiovascular risk natriuretic peptides prediabetes type 2 diabetes mellitus
Online Access:	http://www.heartmindjournal.org/article.asp?issn=2468-6476;year=2020;volume=4;issue=4;spage=100;epage=108;aulast=Berezin

Similar Items

Serum Levels of Irisin Predict Cumulative Clinical Outcomes in Heart Failure Patients With Type 2 Diabetes Mellitus
by: Alexander A. Berezin, et al.
Published: (2022-05-01)

Predictive value of serum irisin for chronic heart failure in patients with type 2 diabetes mellitus
by: Alexander A. Berezin, et al.
Published: (2022-11-01)

The Impact of SGLT2 Inhibitor Dapagliflozin on Adropin Serum Levels in Men and Women with Type 2 Diabetes Mellitus and Chronic Heart Failure
by: Alexander A. Berezin, et al.
Published: (2023-02-01)

The Effect of SGLT2 Inhibitor Dapagliflozin on Serum Levels of Apelin in T2DM Patients with Heart Failure
by: Alexander A. Berezin, et al.
Published: (2022-07-01)

The diagnostic value of brain natriuretic peptide in men with comorbid essential arterial hypertension and type 2 diabetes mellitus
by: Ya. O. Antoniuk, et al.
Published: (2020-10-01)

B-type natriuretic peptide and N-terminal Pro-B-type natriuretic peptide in severe aortic stenosis: a comprehensive literature review
by: Pâmela Nogueira Cavalcante, et al.
Published: (2023-09-01)

The role of brain natriuretic peptide and NT- probrain natriuretic peptide in diagnostics of chronic heart failure and asymptomaticleft ventricular dysfunction in patients with type 2 diabetes mellitus
by: Irina Arkad'evna Bondar', et al.
Published: (2011-09-01)

Natriuretic peptides: Diagnostic and therapeutic use
by: Kaushik Pandit, et al.
Published: (2011-01-01)

The Natriuretic Peptide System: A Single Entity, Pleiotropic Effects
by: Vittoriano Della Corte, et al.
Published: (2023-06-01)

The Effects of Exercise on Natriuretic Peptides in Individuals without Heart Failure
by: Hidetaka Hamasaki
Published: (2016-05-01)

Randomized Trial of the Effects of Insulin and Metformin on Myocardial Injury and Stress in Diabetes Mellitus: A Post Hoc Exploratory Analysis
by: Pratyaksh K. Srivastava, et al.
Published: (2017-12-01)

Discovering a new role for the atrial natriuretic peptide: A novel risk factor for cardiovascular diseases
by: Massimo Volpe, et al.
Published: (2006-09-01)

High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus
by: Yuen-Kwun Wong, et al.
Published: (2019-12-01)

The significance of natriuretic peptides in the evaluation of water-salt metabolism in chronic kidney disease
by: A A Pulin, et al.
Published: (2014-01-01)

DIAGNOSTIC AND PROGNOSTIC VALUES OF B-TYPE NATRIURETIC PEPTIDES AND N-TERMINAL FRAGMENT BRAIN NATRIURETIC PEPTIDES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC KIDNEY DISEASE
by: V. N. Vasilkova, et al.
Published: (2018-02-01)

Clinical Utility of N-Terminal Prohormone B-Type Natriuretic Peptide Levels in Patients of Type 2 Diabetes Mellitus with Heart Failure
by: Sana Iqbal Janjua, et al.
Published: (2023-02-01)

Natriuretic Peptide‐Based Screening to Identify Stage B Heart Failure in People With Type 1 Diabetes
by: William B. Horton, et al.
Published: (2024-02-01)

Low Plasma Levels of Irisin Predict Acutely Decompensated Heart Failure in Type 2 Diabetes Mellitus Patients with Chronic Heart Failure
by: Alexander A. Berezin, et al.
Published: (2023-03-01)

Does brain natriuretic peptide have a significant diagnostic value in subclinical peripheral atrial disease type 2 diabetic patients?
by: Eman M Fahmy, et al.
Published: (2017-01-01)

Natriuretic peptides and their usefulness in clinical practise
by: Aleksandra Skałecka, et al.
Published: (2020-09-01)

Assessment of plasma B-type natriuretic peptide and highly sensitive C- reactive protein among diagnosed patients of diabetes mellitus with and without cardiovascular disease
by: Smriti Rai, et al.
Published: (2024-01-01)

Deterioration of diabetic nephropathy via stimulating secretion of cytokines by atrial natriuretic peptide
by: Chenxiao Liu, et al.
Published: (2021-10-01)

Discriminative Utility of Apelin-to-NT-Pro-Brain Natriuretic Peptide Ratio for Heart Failure with Preserved Ejection Fraction among Type 2 Diabetes Mellitus Patients
by: Alexander A. Berezin, et al.
Published: (2022-01-01)

Determination of B-type natriuretic peptides: Clinical and analytical quality
by: Kovačević Radmila, et al.
Published: (2007-01-01)

Correlation between arterial wall stiffness, N-terminal prohormone of brain natriuretic peptide, functional and structural myocardial abnormalities in patients with type 2 diabetes mellitus and cardiac autonomic neuropathy
by: Viktoriya Alexandrovna Serhiyenko, et al.
Published: (2013-12-01)

From Snake Venoms to Therapeutics: A Focus on Natriuretic Peptides
by: Wei Fong Ang, et al.
Published: (2022-09-01)

Natriuretic peptides appeared after their receptors in vertebrates
by: Anna Grandchamp, et al.
Published: (2019-11-01)

Association of B-Type Natriuretic Peptide Level with Clinical Outcome in Out-of-Hospital Cardiac Arrest in Emergency Department Patients
by: Heejin Hong, et al.
Published: (2023-07-01)

Natriuretic Peptides: It Is Time for Guided Therapeutic Strategies Based on Their Molecular Mechanisms
by: Giovanna Gallo, et al.
Published: (2023-03-01)

Editorial: Natriuretic Peptides in Cardiovascular Pathophysiology
by: Massimo Volpe, et al.
Published: (2022-05-01)

Diagnostic value of atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP) and their correlation with lipoproteins in dogs with myxomatous mitral valve disease
by: Zohreh Khaki, et al.
Published: (2022-12-01)

Molecular Signaling Mechanisms and Function of Natriuretic Peptide Receptor-A in the Pathophysiology of Cardiovascular Homeostasis
by: Kailash N. Pandey
Published: (2021-08-01)

INTEGRATION OF BIOMARKERS INTO THE PRACTICE OF TREATING PATIENTS WITH HEART FAILURE: THE ROLE OF DETERMINING THE BLOOD LEVEL OF NATRIURETIC PEPTIDES
by: S. R. Gilyarevskiy, et al.
Published: (2017-12-01)

Association of circulating B-type natriuretic peptide with osteoporosis in a Chinese type 2 diabetic population
by: Pan Chen, et al.
Published: (2021-03-01)

Modified natriuretic peptides and their potential roles in cancer treatment
by: Mengjiao Xu, et al.
Published: (2022-02-01)

NT-proBNP as a predictor of death and cardiovascular events in patients with type 2 diabetes
by: Marcus Vinicius Bolivar Malachias, et al.
Published: (2022-05-01)

MARKERS OF ACCELERATED CONVERSION OF DIABETES MELLITUS IN VARIOUS CARDIOVASCULAR RISK PATIENTS
by: M. N. Mamedov, et al.
Published: (2016-12-01)

Role of C-type natriuretic peptide in the function of normal human sperm
by: Hui Xia, et al.
Published: (2016-01-01)

Discriminative Value of Serum Irisin in Prediction of Heart Failure with Different Phenotypes among Patients with Type 2 Diabetes Mellitus
by: Alexander A. Berezin, et al.
Published: (2022-09-01)

Natriuretic Peptide and Cardiovascular Risk: Is It About “U”?
by: Christopher R. deFilippi, et al.
Published: (2015-05-01)